Vanderbilt Heart One Hundred Oaks is a clinical research site located in Nashville, Tennessee, United States 37204.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Vanderbilt Heart One Hundred Oaks has participated in 2 clinical trials.
Therapeutic areas: Moderate to Severe Ulcerative Colitis, Breast Cancer, Cardiac Toxicity.
Sponsors: Hoffmann-La Roche, Vanderbilt University.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt Heart One Hundred Oaks has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt Heart One Hundred Oaks has 2 clinical trials on record. Their work covers Moderate to Severe Ulcerative Colitis, Breast Cancer, Cardiac Toxicity.
Vanderbilt Heart One Hundred Oaks has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.